CA-MA

General Information


DRACP ID  DRACP00002

Peptide Name   CA-MA

Sequence  KWKLFKKIGIGKFLHSAKKF

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Ceropin-Magainin hybrid peptides

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia IC50=65 µM MTT assay 3 days 1
A549 Lung adenocarcinoma Carcinoma IC50=60 µM MTT assay 3 days 1
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia IC50=30 µM MTT assay 3 days 1
MDA-MB-361 Breast adenocarcinoma Carcinoma IC50=44 µM MTT assay 3 days 1
NCI-H128 Lung small cell carcinoma; Small cell lung cancer Carcinoma IC50=16.1 µM MTT assay 72 h 2
NCI-H69 Lung small cell carcinoma; Small cell lung cancer Carcinoma IC50=15.8 µM MTT assay 72 h 2
NCI-H146 Lung small cell carcinoma; Small cell lung cancer Carcinoma IC50=15.8 µM MTT assay 72 h 2

Hemolytic Activity  Human erythrocytes (Hemolysis 0% =100 μM)

Normal (non-cancerous) Cytotoxicity  NIH-3T3 fibroblast: IC50>100 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  1D9J 

Predicted Structure  DRACP00002

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C120H190N30O22

Absent amino acids  CDEMNPQRTVY

Common amino acids  K

Mass  274410

Pl  11.58

Basic residues  8

Acidic residues  0

Hydrophobic residues  9

Net charge  8

Boman Index  -1227

Hydrophobicity  -31

Aliphatic Index  83

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  289.47

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 10675500

Title  Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells

Doi 10.1016/s0005-2736(99)00210-2

Year  2000

Literature 2

Pubmed ID 9352466

Title  Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides

Doi 10.1111/j.1399-3011.1997.tb01469.x

Year  1997

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.